These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7129911)

  • 1. [Value of impulse cytophotometry for the diagnosis and prognosis of bladder cancer].
    Blech M; Zimmermann A; Truss F
    Helv Chir Acta; 1982 Aug; 49(3-4):415-8. PubMed ID: 7129911
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved application of impulse cytophotometry for the diagnosis of urinary bladder carcinoma.
    Schwabe HW; Adolphs HD
    Urol Res; 1982; 10(2):61-6. PubMed ID: 6180538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of flow cytometry in diagnosis of urinary bladder cancer].
    Bozhenko VK; Kaprin AD; Kostin AA; Kulinich TM; Kudinova EA; Chazova NL; Mel'nikova NV; Nesterov PV
    Vopr Onkol; 2007; 53(4):468-72. PubMed ID: 17969413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ductal cytometry of urinary sediment in the diagnosis of bladder cancer].
    Bozhenko BK; Kaprin AD; Kulinich TM; Nesterov PV
    Vopr Onkol; 2009; 55(3):278-84. PubMed ID: 19670726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Flow cytometry in diagnosis and treatment of bladder tumor].
    Sun XJ; Song ZL; Wu DC
    Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ductal cytofluorometry of urine sediment level in the diagnosis of bladder cancer].
    Kaprin AD; Bozhenko VK; Kulinich TM; Nesterov PV; Kostin AA
    Vopr Onkol; 2006; 52(5):579-81. PubMed ID: 17168371
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
    Norming U
    Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Flow cytometry in cancer of the bladder].
    Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
    Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
    Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
    Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of urinary cytology for detection of bladder cancer.
    Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
    Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the urinary bladder: prognosis of the outcome].
    Zimichev AA; Prianichnikova MB; Maklakov VN
    Urologiia; 2009; (3):52-3. PubMed ID: 19673123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic aspects of bladder cancer.
    Kim WJ; Quan C
    J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of cytological study by flow cytometry or analysis of image as a complement to macroscopic study by cytoscopy. Apropos of therapeutic follow-up of a case of tumor of the bladder].
    Lizard G; Dusserre-Guion L; Proignot P; Tremeaux JC; Bejui-Thivolet F
    Arch Anat Cytol Pathol; 1993; 41(1):38-44. PubMed ID: 8517763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometry in urinary tract malignancies. II. Methods of removing leukocytes from bladder washing specimen and fixation].
    Matsuura T; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1982 Jun; 73(6):809-15. PubMed ID: 7143852
    [No Abstract]   [Full Text] [Related]  

  • 18. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.
    Wheeless LL; Badalament RA; de Vere White RW; Fradet Y; Tribukait B
    Cytometry; 1993; 14(5):478-81. PubMed ID: 8354118
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder cancer screening.
    Kryger JV; Messing E
    Semin Oncol; 1996 Oct; 23(5):585-97. PubMed ID: 8893869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytofluorometry and tumors of the bladder].
    Devonec M
    Acta Urol Belg; 1983; 51(1):31. PubMed ID: 6858795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.